NCT00280852View on ClinicalTrials.gov

Review of Multimodality Management of Anaplastic Thyroid Cancer

CompletedOBSERVATIONAL

Enrollment

5

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Anaplastic Thyroid Cancer

Trial Locations (1)

T2N 4N2

Tom Baker Cancer Centre, Calgary

All Listed Sponsors

lead

Alberta Health services

OTHER

NCT00280852 - Review of Multimodality Management of Anaplastic Thyroid Cancer | Biotech Hunter | Biotech Hunter